In the past week, AGEN stock has gone down by -16.62%, with a monthly decline of -1.49% and a quarterly plunge of -50.90%. The volatility ratio for the week is 9.01%, and the volatility levels for the last 30 days are 11.13% for Agenus Inc. The simple moving average for the past 20 days is -7.01% for AGEN’s stock, with a -64.69% simple moving average for the past 200 days.
Is It Worth Investing in Agenus Inc (NASDAQ: AGEN) Right Now?
The 36-month beta value for AGEN is also noteworthy at 1.25. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 4 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for AGEN is 22.37M, and at present, short sellers hold a 12.31% of that float. The average trading volume of AGEN on December 13, 2024 was 487.34K shares.
AGEN) stock’s latest price update
Agenus Inc (NASDAQ: AGEN)’s stock price has gone decline by -3.08 in comparison to its previous close of 3.08, however, the company has experienced a -16.62% decrease in its stock price over the last five trading days. businesswire.com reported 2024-12-05 that LEXINGTON, Mass.–(BUSINESS WIRE)–Agenus Inc., a leader in immuno-oncology, today announced further details of its strategic realignment aimed at streamlining operations, strengthening its financial position, and prioritizing the advancement of its most impactful programs as it prepares for 2025. Reductions are designed to reduce cash burn to $100 million in FY 2025. This initiative follows the successful closing of a $22 million mortgage secured by key real estate assets, providing the compan.
Analysts’ Opinion of AGEN
Many brokerage firms have already submitted their reports for AGEN stocks, with Robert W. Baird repeating the rating for AGEN by listing it as a “Neutral.” The predicted price for AGEN in the upcoming period, according to Robert W. Baird is $8 based on the research report published on July 19, 2024 of the current year 2024.
H.C. Wainwright gave a rating of “Neutral” to AGEN, setting the target price at $9 in the report published on July 18th of the current year.
AGEN Trading at -22.18% from the 50-Day Moving Average
After a stumble in the market that brought AGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.84% of loss for the given period.
Volatility was left at 11.13%, however, over the last 30 days, the volatility rate increased by 9.01%, as shares surge +7.94% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -34.43% lower at present.
During the last 5 trading sessions, AGEN fell by -16.48%, which changed the moving average for the period of 200-days by -77.69% in comparison to the 20-day moving average, which settled at $3.21. In addition, Agenus Inc saw -81.97% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AGEN starting from ARMEN GARO H, who purchase 500,000 shares at the price of $0.65 back on Feb 15 ’24. After this action, ARMEN GARO H now owns 625,969 shares of Agenus Inc, valued at $324,050 using the latest closing price.
Stock Fundamentals for AGEN
Current profitability levels for the company are sitting at:
- -0.62 for the present operating margin
- 0.69 for the gross margin
The net margin for Agenus Inc stands at -1.42. The total capital return value is set at 3.08.
Currently, EBITDA for the company is -145.92 million with net debt to EBITDA at -0.13. When we switch over and look at the enterprise to sales, we see a ratio of 0.5. The receivables turnover for the company is 775.01for trailing twelve months and the total asset turnover is 0.67. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.19.
Conclusion
In summary, Agenus Inc (AGEN) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
